article · Antimicrobial Agents and Chemotherapy

Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084

Mark A. Marzinke
Susan L. Ford
Mina C. Hosseinipour
Adeola Adeyeye
Myron S. Cohen
Rogers Sekabira
Elizabeth Spooner
James F. Rooney
Kelong Han
Craig W. Hendrix
Steven Innes
Mercy Mutambanengwe
Brett Hanscom
Carrie Mathew
Alex R. Rinehart
Xu Guo
Estelle Piwowar-Manning
Scott Rose
Sinéad Delany‐Moretlwe

20242 citationsOpen accessUniversity of the Witwatersrand

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

This study is registered with ClinicalTrials.gov as NCT03164564.

Research topics

HIV/AIDS Research and Interventions
HIV Research and Treatment
HIV/AIDS drug development and treatment

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1128/aac.00994-24

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.